journal article·2016-09Open access

Oxygen‐Boosted Chemotherapy: Oxygen Nanocarrier for Combined Cancer Therapy: Oxygen‐Boosted ATP‐Responsive Chemotherapy with Amplified ROS Lethality (Adv. Healthcare Mater. 17/2016)

Pengfei Zhao, Mingbin Zheng, Zhenyu Luo, Xiujun Fan, Zonghai Sheng, Ping Gong, Ze Chen, Baozhen Zhang, Dapeng Ni, Yifan Ma, Lintao Cai

Advanced Healthcare Materials· Volume 5· Issue 17

Abstract

An oxygen nanocarrier (A/D-ONC) absorbing doxorubicin-intercalated DNA duplex is developed by Jin Chang, Nan Ma, Rainer Haag and co-workers on page 2161. After cell endocytosis, oxygenated A/D-ONC donates O2 to cancer cells for therapy by two ways: 1) increase intracellular ATP content to promote ATP-responsive DOX release for chemotherapy, converting ATP to the activator of detrimental chemotherapy; 2) synchronously increase reactive oxygen species (ROS) amount to amplify the lethality to cancer cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Key Laboratory of Nanomedicine Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 P. R. China

University of Chinese Academy of Sciences Beijing 100049 P. R. China

Guangdong Key Laboratory for Research and Development of Natural Drugs Guangdong Medical University Dongguan 523808 P. R. China

State Key Laboratory of Chemo/Biosensing and Chemometrics Hunan University Changsha 410082 P. R. China

Research Laboratory for Reproductive Health Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 P. R. China

References

Reference metadata was not supplied for this record.